IL2 and neoplasm: Likewise, Liu et al. [128] developed a multiadjuvant whole-cell tumor vaccine (WCTV) based on PLGA NPs modified with a cell-penetrating peptide, which resulted in GM-CSF and IL-2 distribution into tumor cells.